A retrospective, cohort study assessing the effectiveness, safety, and adherence to guselkumab in psoriasis refractory to biologic therapies
Latest Information Update: 28 Jun 2022
At a glance
- Drugs Guselkumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Jun 2022 Results published in the International Journal of Clinical Pharmacy
- 11 Apr 2022 New trial record
- 05 Apr 2022 Results published in the International Journal of Clinical Pharmacy